See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

Teva Pharmaceutical Industries has seen its fair value price target rise from $24.44 to $27.45, reflecting renewed optimism ...

Phoenix Financial recently acquired more than 3.5 million additional shares of Teva Pharmaceutical Industries in the third ...

NYSE:TEVA Earnings and Revenue History November 12th 2025 How Do Unusual Items Influence Profit? For anyone who wants to ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund reported holding ...

Teva Pharmaceutical Industries is able to absorb any potential tariffs imposed by the Trump administration, the company said ...

Teva Pharmaceutical Industries TEVA reported third-quarter 2025 adjusted earnings of 78 cents per share, which beat the Zacks ...

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday outlined that Weiss executed a sale ...

Teva Pharmaceutical Industries (NYSE: TEVA) had a day on the stock market to remember on Wednesday. The drugmaker 's share ...

The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday. By Sarah Maslin Nir The agency cited Teva’s continuing supply problems as well as those of other drug ...